LONG-TERM NEUROSTIMULATOR PROGRAMMING IN A LARGE PROSPECTIVE TRIAL OF SACRAL NEUROMODULATION THERAPY FOR OVERACTIVE BLADDER PATIENTS

被引：0

作者：

Siegel, S. ^{[1
]}

Mangel, J. ^{[2
]}

Bennett, J. ^{[3
]}

Comiter, C., V ^{[4
]}

Zylstra, S. ^{[5
]}

Bird, E. ^{[6
]}

Griebling, T. L. ^{[7
]}

Sutherland, S. E. ^{[8
]}

Berg, Chase K. ^{[9
]}

Kan, F. ^{[9
]}

机构：

[1] Metro Urol, Woodbury, MN USA

[2] MetroHlth Med Ctr, Cleveland, OH USA

[3] Mercy Hlth Pelv Med & Urogynecol, St Louis, MO USA

[4] Stanford Univ, Stanford, CA 94305 USA

[5] Milford Reg Med Ctr, Milford, MA USA

[6] Scott & White Healthcare, Dallas, TX USA

[7] Univ Kansas, Lawrence, KS 66045 USA

[8] Univ Washington, Seattle, WA 98195 USA

[9] Medtronic, Minneapolis, MN USA

来源：

NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

435

引用

页码：S282 / S282

页数：1

共 50 条

[41] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial [J].

Amundsen, Cindy L. ;

Richter, Holly E. ;

Menefee, Shawn ;

Vasavada, Sandip ;

Rahn, David D. ;

Kenton, Kim ;

Harvie, Heidi S. ;

Wallace, Dennis ;

Meikle, Susie .

CONTEMPORARY CLINICAL TRIALS, 2014, 37 (02) :272-283

[42] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial [J].

Hall, Evelyn .

OBSTETRICS AND GYNECOLOGY, 2017, 129 (01) :201-201

[43] Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms [J].

van de Borne, Sigrid ;

Tilborghs, Sam ;

Vaganee, Donald ;

Vermandel, Alexandra ;

De Wachter, Stefan .

NEUROMODULATION, 2023, 26 (08) :1831-1835

[44] SELF-REPORTED MEDICATION COSTS IN PATIENTS RECEIVING SACRAL NEUROMODULATION FOR OVERACTIVE BLADDER [J].

Williams, M. J. ;

Hinnenthal, J. ;

Zylstra, S. ;

Mangel, J. ;

Comiter, C. ;

Bird, E. ;

Griebling, T. ;

Culkin, D. ;

Sutherland, S. ;

Noblett, K. ;

Siegel, S. .

VALUE IN HEALTH, 2015, 18 (07) :A352-A352

[45] Do patients experience decisional regret after sacral neuromodulation for refractory overactive bladder? [J].

Kessler, Leia ;

Illinsky, Daniel ;

Laudano, Melissa ;

Abraham, Nitya E. .

NEUROUROLOGY AND URODYNAMICS, 2024, 43 (01) :22-30

[46] SACRAL NEUROMODULATION IN TREATING OVERACTIVE BLADDER PATIENTS - FIRST-TIME APPLICATION IN CROATIA [J].

Bakula, Mirko ;

Hauptman, Dinko ;

Hudolin, Tvrtko ;

Skegro, Sandra Nad ;

Tudor, Katarina Ivana ;

Bakula, Branko ;

Kastelan, Zeljko .

ACTA CLINICA CROATICA, 2023, 62 :143-147

[47] Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction:: Long-term results with unilateral implants [J].

Hohenfellner, M ;

Humke, J ;

Hampel, C ;

Dahms, S ;

Matzel, K ;

Roth, S ;

Thüroff, JW ;

Schultz-Lampel, D .

UROLOGY, 2001, 58 (06) :887-892

[48] Efficacy of Sacral Neuromodulation in Treatment of Bladder Pain Syndrome: Long-Term Follow-Up [J].

Ghazwani, Yahya Q. ;

Elkelini, Mohamed S. ;

Hassouna, Magdy M. .

NEUROUROLOGY AND URODYNAMICS, 2011, 30 (07) :1271-1275

[49] Sacral neuromodulation: long-term outcome and quality of life in patients with faecal incontinence [J].

Uludag, O. ;

Melenhorst, J. ;

Koch, S. M. P. ;

van Gemert, W. G. ;

Dejong, C. H. C. ;

Baeten, C. G. M. I. .

COLORECTAL DISEASE, 2011, 13 (10) :1162-1166

[50] Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study [J].

Kaaki, Bilal ;

Gupta, Digant .

PLOS ONE, 2020, 15 (07)

← 1 2 3 4 5 →